Day: April 2, 2025

Norwegian Utility to Deploy Itron’s Distributed Intelligence-Enabled Smart Meters to Modernize Grid LIBERTY LAKE, Wash., April 02, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, is working together with Norwegian energy utility, Norgesnett, on the first-ever edge computing deployment in the Nordics with Itron’s Grid Edge Intelligence portfolio, which includes distributed intelligence (DI)-enabled smart meters. As part of Norgesnett’s Advanced Metering Infrastructure (AMI) grid modernization roadmap, the utility will leverage DI to gain greater distribution system visibility and control at the grid edge, from the consumer to the substation. By enabling edge computing, DI lays the foundation for efficient adoption and flexibility of distributed...

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham Virtual Healthcare Conference, taking place from April 7-10, 2025. In addition, CEO Josh Riggs will participate in a fireside chat at the conference. During the event, Josh and Andrea will discuss Oncocyte’s innovative diagnostic technologies and will highlight the company’s progress toward commercializing a regulated organ transplant rejection monitoring test kit. The company is pursuing a market-disruptive approach, positioning Oncocyte to lead the way in advancing transplant monitoring solutions. Investors wishing to attend the virtual fireside chat or schedule one-on-one meetings...

Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026 Alignment through recent interactions with CDER on path to accelerated approval and conversion to full approval for tividenofusp alfa Productive collaboration continues under START for an accelerated development and approval path for DNL126SOUTH SAN FRANCISCO, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the company’s initiation of a rolling submission of a biologics license application (BLA) for accelerated approval of tividenofusp alfa for the treatment of Hunter syndrome (MPS II) has been received by the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA). Denali continues to have...

SYDNEY, AUSTRALIA , April 02, 2025 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces its management will present and participate in one-on-one meetings at the following investor conferences:   Jones Healthcare and Technology Innovation Conference  Location: Las Vegas, NV  Date:         Wednesday, 9 April 2025  Time: 4:30 pm ET       The Citizens Life Sciences ConferenceLocation: New York, NYDate: Thursday, 8 May 2025Time: 1:00 pm ET Jefferies Global Healthcare ConferenceLocation:  New York, NYDate: Wednesday & Thursday, 4 & 5 June 2025   Additional information for the Jefferies presentation will be made available closer to the conference on...

MALMÖ, Sweden, April 02, 2025 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY), the world’s original and largest oat drink company, will report financial results for the first quarter ended March 31, 2025, on Wednesday April 30, 2025 before the U.S. market opens. Oatly will host a conference call and webcast at 7:30 a.m. ET on the same day to discuss the results. The conference call and simultaneous live webcast can be accessed on Oatly’s Investors website at https://investors.oatly.com under “Events.” The webcast will be archived for 30 days. About Oatly We are the world’s original and largest oat drink company. For over 30 years, we have exclusively focused on developing expertise around oats: a global power crop with inherent properties. Our commitment to oats has resulted in core technical advancements that enabled us to unlock...

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that management will present at the 24th Annual Needham Virtual Healthcare Conference, which is taking place from April 7-10, 2025, to discuss the company’s pipeline, platform, and business strategy. Participating will be Ben Zeskind, Chief Executive Officer, Brett Hall, Chief Scientific Officer, Igor Matushansky, Chief Medical Officer, Harold “E.B.” Brakewood, Chief Business Officer, Michael Bookman, Chief Legal Officer, Secretary and Mallory Morales, CPA, Chief Accounting Officer, Treasurer. Format: Company Presentation and 1×1 Investor Meetings Date/Time: April 9 from 1:30 – 2:10...

ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) — — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman and Chief Executive Officer Michael Benstock was interviewed on the Smart Money Circle podcast, hosted by renowned investor Adam Sarhan. The interview is now available for viewing on the Smart Money Circle YouTube channel. Investors can also access the interview via Superior Group of Companies’ website at https://ir.superiorgroupofcompanies.com/presentations. About Superior Group of Companies, Inc. (SGC):Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary...